Life Sciences: Commercial Strategy

Commercial Strategy

CRA helps life sciences companies develop superior commercial strategies strategies based on sound market fundamentals – from launch strategy to portfolio optimization to franchise expansion. We have the analytical tools and market experience needed to make the most out of your product launch.

Strategic support throughout the lifecycle

CRA creates commercial strategies that optimize ROI at launch and throughout the lifecycle

Early development
  • Market, competitor, and stakeholder
  • Needs assessment
  • Commercial attractiveness vs investment requirements
  • Forecasting
  • Asset go-no-go decision making
Late development
  • Brand planning
  • Channel identification
  • Patient flow and journey
  • Stakeholder value drivers
  • Segmentation and targeting
  • Brand strategy
  • Brand and Launch Maxximizer
  • Promotional strategies
  • Competitive strategies
  • War gaming
Life cycle & LOE
  • Launch assessments
  • Brand strategy audit
  • Growth strategies - market opportunities, brand extensions, or service offering
  • Competitor defense strategies

Sample engagements

Prioritizing strategic options to support launch planning
Go-to-market strategy for follow-on asset with blockbuster potential
Portfolio growth strategy
Biosimilars impact and strategy
Pre-launch competitive assessment in neurology

Our life sciences practice is made up of 185 consultants that blend decades of global business experience with an extensive understanding of life sciences.

Meet our senior team >